Abstract
Carbohydrazides of N-substituted β-amino acids exhibit a variety of different biological activities including antibacterial, antiviral, fungicidal, antihelminthic, anticancer, antiinflammatory, etc. New potentially biologically active N-(4-iodophenyl)-β-alanine derivatives, N-(4-iodophenyl)-N-carboxyethyl-β-alanine derivatives, and their cyclization products were designed and synthesized. To determine the most propitious directions for further investigation of the obtained compounds, we tried to appraise their biological activity in silico using the ChemSpider and chemical structure lookup service (CSLS), chemical similarity assessment (Integrity and SuperPred), and machine learning methods [prediction of activity spectra for substances (PASS)]. No useful hints on potential biological activity of the obtained novel compounds were delivered by ChemSpider, CSLS, Integrity or SuperPred. In contrast, PASS predicted some biological activities that could be verified experimentally. Neither antibacterial nor antifungal activity was predicted for the compounds under study despite these actions being known for compounds from this chemical class. Evaluation of antibacterial (Escherichia coli B-906, Staphylococcus aureus 209-P, and Mycobacterium luteum B-91) and antifungal (Candida tenuis VKM Y-70 and Aspergillus niger F-1119) activities in vitro did not reveal any significant antimicrobial action, which corresponds to the computational prediction. Advantages and shortcomings of chemical similarity and machine learning techniques in computational assessment of biological activities are discussed. Based on the obtained results, we conclude that academic organic chemistry studies could provide a significant impact on drug discovery due to the novelty and diversity of the designed and synthesized compounds; however, practical utilization of this potential is narrowed by the limited facilities for assaying biological activities.
Similar content being viewed by others
References
E. Juaristi, A. Soloshonok, Enantioselective synthesis of β-aminoacids (Wiley, New York, 2005)
K. Anusevičius, I. Jonuškienė, V. Mickevičius, Monatsh. Chem. 144, 1883 (2013)
S. Pelosi Jr., US Pat. 1976/3980689, Dec.14 (1976)
T. Aboul-Fadl, A.R. Khallil, Arzneim. Forsch. 53, 526 (2003)
V. Mickevicius, A. Voskienė, I. Jonuskienė et al., Molecules 18, 15000 (2013)
I. Jonuskiene, S. Kuusiene, V. Mickevicius, Chem. Technol. 49, 53 (2008)
H. Habashita, M. Terakado, S. Nakade, T. Seko, US Patent 2005/0256160 A1. 17 Nov 2005
S. Dekeukeleire, M. D’hooghe, K.W. Turnroos, N. De Kimpe, J. Org. Chem. 75, 5934 (2010)
I. Ojima, S. Inaba, M. Nagai, Synthesis 7, 545 (1981)
S. Kanwar, S.D. Sharma, ChemInform 37, 11 (2006)
V. Mickevicius, R. Vaickelioniene, G. Mikulskiene, N. Sewald, Chem. Heterocycl. Compd. 6, 874 (2005)
K. Anusevičius, I. Jonuskienė, V. Mickevicius, Monatsh. Chem. 144, 1883 (2013)
V.K. Tiwari, N. Tewary, D. Katiyjar, R.P. Tripathi, Monatsh. Chem. 138, 1297 (2007)
R. Vaickelioniene, V. Mickevicius, G. Mikulskiene, Molecules 10, 407 (2005)
R. Patino-Molina, I. Cubero-Lajo, M.J. Perez de Vega, M.T. Garcia Lopez, R. Gonzalez-Muniz, Tetrahedron Lett. 48, 3613 (2007)
J.R. Merchant, D.S. Clothia, J. Chem. Soc. Perkin Trans. 1, 932 (1972)
O. Prakash, D. Kumar, R.K. Saini, S.P. Singh, Synth. Commun. 15, 2167 (1994)
V. Novikovaite, Z.J. Beresnevicius, G. Mikulskiene, Chem. Heterocycl. Compd. 43(1), 113 (2007)
I. Tumosienė, K. Jonuskienė, Z. Kantminienė, J. Beresnevicius, Monatsh. Chem. 143, 1441 (2012)
K. Anusevicius, V. Mickevicius, G. Mikulskiene, Chemija 21, 127 (2010)
A.S. Anees, A. Amit, N. Sidqui, M. Amit, Indian J. Chem. Sect. B 44, 838 (2005)
H. Bektaş, N. Karaali, D. Şahin, A. Demirbaş, Ş.A. Karaoglu, N. Demirbaş, Molecules 15, 2427 (2010)
W.L. Jorgensen, Science 303, 1813 (2004)
L.W. Tari, Structure-based drug discovery. Methods Mol. Biol. 841, 1–385 (2012)
K. Heikamp, J. Bajorath, Chem. Biol. Drug Des. 81, 33 (2013)
K. Anusevicius, R. Vaickelioniene, V. Mickevicius, G. Mikulskiene, J. Heterocycl. Chem. 50, 309 (2013)
http://www.accelrys.com. Accessed 2014
http://www.chemspider.com. Accessed 2014
http://www.cactus.nci.nih.gov/cgi-bin/lookup/search. Accessed 2014
http://www.integrity.thomson-pharma.com. Accessed 2014
Y.C. Martin, J.L. Kofron, L.M. Traphagen, J. Med. Chem. 45, 4350 (2002)
http://www.bioinformatics.charite.de/superpred. Accessed 2014
M. Dunkel, S. Günther, J. Ahmed, B. Wittig, R. Preissner, Nucleic Acids Res. 36, W55 (2008)
C. Steinbeck, C. Hoppe, S. Kuhn, M. Floris, R. Guha, E.L. Willighagen, Curr. Pharm. Des. 12, 2111 (2006)
http://www.way2drug.com/passonline. Accessed 2014
D.A. Filimonov, V.V. Poroikov, in Chemoinformatics approaches to virtual screening, ed. by A. Varnek, A. Tropsha (RSC Publishing, Cambridge, 2008), pp. 182–216
D. Filimonov, V. Poroikov, Yu. Borodina, T. Gloriozova, J. Chem. Inf. Comput. Sci. 39, 666 (1999)
A. Lagunin, A. Stepanchikova, D. Filimonov, V. Poroikov, Bioinformatics 16, 747 (2000)
A. Sadym, A. Lagunin, D. Filimonov, V. Poroikov, SAR QSAR Environ. Res. 14, 339 (2003)
A. Geronikaki, D. Druzhilovsky, A. Zakharov, V. Poroikov, SAR QSAR Environ. Res. 19, 27 (2008)
V. Poroikov, A. Lagunin, D. Filimonov, in QSAR and molecular modelling in rational design of bioactive molecules, ed. by E. Aki Sener, I. Yalcin (CADD & D Society, Ankara, 2005), pp. 514–515
A. Geronikaki, V. Poroikov, D. Hadjipavlou-Litina, D. Filimonov, A. Lagunin, R. Mgonzo, Quant. Struct. Activ. Relationsh. 18, 16 (1999)
M.J. Walport, N. Engl, J. Med. 344, 1058 (2001)
M.J. Walport, N. Engl, J. Med. 344, 1140 (2001)
W.C. Song, M.R. Sarrias, J.D. Lambris, Immunopharmacology 49, 187 (2000)
E. Munthe, H.M. Hoyeraal, S.S. Froland, O.J. Mellbye, E. Kess, J.B. Natvig, Rheumatology 6, 43 (1975)
S. Ruddy, K.F. Austen, Ann. N.Y. Acad. Sci. 256, 96 (1975)
O. Radillo, A. Nocera, A. Leprini, S. Barocci, T.E. Mollnes, M. Pocecco, M. Pausa, U. Valente, C. Betterle, F. Tedesco, Clin. Immunol. Immunopathol. 79, 217 (1996)
S.J. Piddlesden, S. Jiang, J.L. Levin, A. Vincent, B.P. Morgan, J. Neuroimmunol. 71, 173 (1996)
L.H. Perrin, P.H. Lambert, P.A. Miescher, J. Clin. Invest. 56, 165 (1975)
M. Chrupcala, S. Pomer, G. Staehler, R. Waldherr, C. Kirschfink, Transpl. Int. 7, 650 (1994)
B.G. Hoffstrom, A. Kaplan, R. Letso, R. Schmid, G.J. Turmel, D.C. Lo, B.R. Stockwell, Nat. Chem. Biol. 6, 900 (2010)
S. Madhusudan, I.D. Hickson, Trends Mol. Med. 11, 503 (2005)
M. Allary, J. Schrevel, I. Florent, Parasitology 125, 1 (2002)
M. Flipo, T. Beghyn, V. Leroux, I. Florent, B.P. Deprez, R.F. Deprez-Poulain, J. Med. Chem. 50, 1322 (2007)
R.B. Gennis, B. Barquera, B. Hacker, D.S.R. Van, S. Arnaud, A.R. Crofts, E. Davidson, K.A. Gray, F. Daldal, J. Bioenerg. Biomembr. 25, 195 (1993)
E. Darrouzet, M. Valkova-Valchanova, T. Ohnishi, F. Daldal, J. Bioenerg. Biomembr. 31, 275 (1999)
S. Ouchane, I. Agalidis, C. Astier, J. Bacteriol. 184, 3815 (2002)
S.O. Pember, L.C. Fleck, W.K. Moberg, M.P. Walker, Arch. Biochem. Biophys. 435, 280 (2005)
Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-11th edn, Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, (2012)
Method for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-9th edn, Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, (2012)
J. Frearson, P. Wyatt, Expert Opin. Drug Discov. 5, 909 (2010)
W. Rhodes, J. Transl. Med. 10(Suppl 2), A42 (2012)
D.M. Huryn, L.O. Resnick, P. Wipf, J. Med. Chem. 56, 7161 (2013)
S. Ekins, B.A. Bunin, Methods Mol. Biol. 993, 139 (2013)
L. Esser, B. Quinn, Y. Li, M. Zhang, M. Elberry, L. Yu, C.A. Yu, D. Xia, J. Mol. Biol. 341, 281 (2004)
V.V. Poroikov, D.A. Filimonov, J. Comput. Aid. Molec. Des. 11, 819 (2002)
A.A. Lagunin, O.A. Gomazkov, D.A. Filimonov, T.A. Gureeva, E.A. Dilakyan, E.V. Kugaevskaya, YuE Elisseeva, N.I. Solovyeva, V.V. Poroikov, J. Med. Chem. 46, 3326 (2003)
A.A. Geronikaki, A.A. Lagunin, D.I. Hadjipavlou-Litina, PhT Eleftheriou, D.A. Filimonov, V.V. Poroikov, I. Alam, A.K. Saxena, J. Med. Chem. 51, 1601 (2008)
S.A. Kryzhanovskii, R.M. Salimov, A.A. Lagunin, D.A. Filimonov, T.A. Gloriozova, V.V. Poroikov, Pharm. Chem. J. 45, 605 (2012)
A. Lagunin, D.A. Filimonov, V.V. Poroikov, Curr. Pharm. Des. 16, 1703 (2010)
Acknowledgments
This work was performed with partial financial support of the State Fund for Fundamental Research of Ukraine (agreement F53/97-2013) and the Russian Foundation for Basic Research (projects 13-04-90425, 12-07-00597).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Anusevicius, K., Mickevicius, V., Stasevych, M. et al. Synthesis and chemoinformatics analysis of N-aryl-β-alanine derivatives. Res Chem Intermed 41, 7517–7540 (2015). https://doi.org/10.1007/s11164-014-1841-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-014-1841-0